Schedule 13D ownership disclosure

Immunoclin Corp

Security class unavailable · CUSIP: 45256L109

Event date: 2013-04-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
38.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001571049-16-013912
Form type
SC 13D
Filer
Dabney Raymond C.
CIK
CIK 1630848
Filed
Apr 14, 2016
Reporting period
Apr 05, 2013
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub